HAEK Stock Overview
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
HAEMATO AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €20.60 |
52 Week High | €22.60 |
52 Week Low | €13.65 |
Beta | 1.3 |
1 Month Change | 13.19% |
3 Month Change | -3.74% |
1 Year Change | -3.74% |
3 Year Change | -3.74% |
5 Year Change | -65.08% |
Change since IPO | -49.76% |
Recent News & Updates
HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20
May 20We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)
May 12HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher
Dec 08Recent updates
HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20
May 20We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)
May 12HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher
Dec 08The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business
May 24HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns
Nov 17HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around
May 30We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate
Mar 08What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?
Feb 15Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)
Jan 25Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?
Jan 04Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years
Dec 14Shareholder Returns
HAEK | DE Healthcare | DE Market | |
---|---|---|---|
7D | 4.6% | -2.5% | -1.3% |
1Y | -3.7% | -21.5% | -8.5% |
Return vs Industry: HAEK exceeded the German Healthcare industry which returned -22.1% over the past year.
Return vs Market: HAEK exceeded the German Market which returned -8.1% over the past year.
Price Volatility
HAEK volatility | |
---|---|
HAEK Average Weekly Movement | 4.8% |
Healthcare Industry Average Movement | 4.3% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 9.9% |
10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: HAEK is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: HAEK's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 76 | Patrick Brenske | https://www.haemato.ag |
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products.
HAEMATO AG Fundamentals Summary
HAEK fundamental statistics | |
---|---|
Market Cap | €106.64m |
Earnings (TTM) | €8.19m |
Revenue (TTM) | €249.07m |
13.1x
P/E Ratio0.4x
P/S RatioIs HAEK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HAEK income statement (TTM) | |
---|---|
Revenue | €249.07m |
Cost of Revenue | €226.53m |
Gross Profit | €22.54m |
Other Expenses | €14.35m |
Earnings | €8.19m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 31, 2023
Earnings per share (EPS) | 1.57 |
Gross Margin | 9.05% |
Net Profit Margin | 3.29% |
Debt/Equity Ratio | 0% |
How did HAEK perform over the long term?
See historical performance and comparisonDividends
5.3%
Current Dividend Yield816%
Payout RatioDoes HAEK pay a reliable dividends?
See HAEK dividend history and benchmarksHAEMATO dividend dates | |
---|---|
Ex Dividend Date | Jul 19 2023 |
Dividend Pay Date | Jul 21 2023 |
Days until Ex dividend | 49 days |
Days until Dividend pay date | 51 days |
Does HAEK pay a reliable dividends?
See HAEK dividend history and benchmarks